Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AdvanDrop Med
- Development stage
- Unknown
- Lead developer
- HealthCann
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
AdvanDrop Med is a liquid formulation that utilizes AdvanDrop™ technology to significantly improve the solubility and oral bioavailability of cannabinoids, primarily Cannabidiol (CBD), in aqueous solutions. This technology aims to accelerate and potentiate the effects of CBD on the body by enhancing its absorption into the bloodstream, leading to a higher concentration and faster action compared to standard CBD oils. Cannabidiol (CBD) is a non-psychotropic cannabinoid that interacts with the endocannabinoid system (ECS) and other receptors. Its complex mechanism of action involves modulating cannabinoid receptors (CB1 and CB2), acting as an agonist on transient receptor potential cation channel subfamily V member 1 (TRPV1) and 5-hydroxytryptamine receptor 1A (5-HT1A), and as an antagonist on G protein-coupled receptor 55 (GPR55). This enhanced delivery system is developed by Healthcann.
- Brand names
- AdvanDrop Med (liquid)
- Other names
- AdvanDrop™ technologyCBD liquid formulation using AdvanDrop™ technology
02
Targets
HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))CNR1 (Cannabinoid receptor 1)GPR55 (G protein-coupled receptor 55)TRPV1 (Transient receptor potential cation channel subfamily V member 1)
Beyond the preview
Go deeper on AdvanDrop Med.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AdvanDrop Med.